Abstract
Objective This study aims to assess the usefulness of monitoring serum α-fetoprotein (AFP) levels for predicting recurrence patterns in patients with hepatocellular carcinoma (HCC) treated with carbon-ion radiotherapy.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have